Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/28790
Title: | Urticaria and angio-oedema due to ziprasidone |
Authors: | Uludağ Üniversitesi/Tıp Fakültesi/Psikiyatri Anabilim Dalı. Uludağ Üniversitesi/Tıp Fakültesi/Dermatoloji Anabilim Dalı. Akkaya, Cengiz Sarandöl, Aslı Aydoğan, Kenan Kirli, Selçuk 14061855100 14020405100 9739755800 14019745700 |
Keywords: | Angio-oedema Adverse cutaneous reactions Risperidone Urticaria Ziprasidone |
Issue Date: | Jul-2007 |
Publisher: | Sage Publications |
Citation: | Akkaya, C. vd. (2007). "Urticaria and angio-oedema due to ziprasidone". Journal of Psychopharmacology, 21(5), 550-552. |
Abstract: | Antipsychotic medications are commonly associated with adverse cutaneous reactions (ACRs) in approximately 5% of patients. Angio-oedema accompanying unticaria is one of the most serious ACRs. The 36-year-old female patient who was diagnosed with 'Paranoid schizophrenia' 6 years ago, was commenced on ziprasidone 120 mg/day. On day 30 of the treatment, the patient presented urticarial papules and plaques all over the body and angio-oedema in the face. The patient was diagnosed as 'Urticaria+Angio-oedema'. The development of ACRs after the initation of ziprasidone monotherapy, disappearance of Lesions after the discontinuation of this antipsychotic, and positive intradermal skin test all suggests a possible causal relationship between ACRs and ziprasidone. To our knowledge, this is the first reported case of unticaria and angio-oedema due to ziprasidone monotherapy. Ziprasidone is a valid and effective choice amongst antipsychotic medications, but this case calls for caution regarding ACRs at the time of prescribing. |
URI: | https://doi.org/10.1177/0269881106075273 https://journals.sagepub.com/doi/10.1177/0269881106075273 http://hdl.handle.net/11452/28790 |
ISSN: | 1461-7285 0269-8811 |
Appears in Collections: | PubMed Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.